Cargando…
Lipidomics reveals association of circulating lipids with body mass index and outcomes in IgA nephropathy patients
IgA nephropathy (IgAN) is a leading cause of chronic kidney disease (CKD), which are commonly accompanied by dyslipidemia. Obesity is also associated with dyslipidemia and risk of CKD, but the relation of the dyslipidemia patterns with obesity and disease progression in IgAN patients remains unknown...
Autores principales: | Deng, Yueyi, Wu, Qingqing, Chen, Wanjia, Zhu, Li, Liu, Wangyi, Xia, Fangying, Sun, Liang, Lin, Xu, Zeng, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697343/ https://www.ncbi.nlm.nih.gov/pubmed/34272854 http://dx.doi.org/10.1093/jmcb/mjab040 |
Ejemplares similares
-
The Application of SILAC Mouse in Human Body Fluid Proteomics Analysis Reveals Protein Patterns Associated with IgA Nephropathy
por: Zhao, Shilin, et al.
Publicado: (2013) -
High-coverage targeted lipidomics could reveal lipid alterations and evaluate therapeutic efficacy of membranous nephropathy
por: Lu, Zhenzhen, et al.
Publicado: (2022) -
Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis
por: Lu, Zhenzhen, et al.
Publicado: (2021) -
Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy
por: Wu, Changwei, et al.
Publicado: (2018) -
The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)